相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。By restoring autophagic flux and improving mitochondrial function, corosolic acid protects against Dox-induced cardiotoxicity
Yan Che et al.
CELL BIOLOGY AND TOXICOLOGY (2022)
Elabela may regulate SIRT3-mediated inhibition of oxidative stress through Foxo3a deacetylation preventing diabetic-induced myocardial injury
Cheng Li et al.
JOURNAL OF CELLULAR AND MOLECULAR MEDICINE (2021)
Resveratrol reduces cardiac NLRP3-inflammasome activation and systemic inflammation to lessen doxorubicin-induced cardiotoxicity in juvenile mice
Zaid H. Maayah et al.
FEBS LETTERS (2021)
Epigallocatechin-3-gallate pretreatment alleviates doxorubicin-induced ferroptosis and cardiotoxicity by upregulating AMPKα2 and activating adaptive autophagy
Huan He et al.
REDOX BIOLOGY (2021)
Regulated cell death pathways in doxorubicin-induced cardiotoxicity
Effimia Christidi et al.
CELL DEATH & DISEASE (2021)
atg7-Based Autophagy Activation Reverses Doxorubicin-Induced Cardiotoxicity
Yong Wang et al.
CIRCULATION RESEARCH (2021)
Elabela gene therapy promotes angiogenesis after myocardial infarction
Liangli Jin et al.
JOURNAL OF CELLULAR AND MOLECULAR MEDICINE (2021)
FNDC5 alleviates oxidative stress and cardiomyocyte apoptosis in doxorubicin-induced cardiotoxicity via activating AKT
Xin Zhang et al.
CELL DEATH AND DIFFERENTIATION (2020)
Doxorubicin induces cardiomyocyte apoptosis and atrophy through cyclin-dependent kinase 2?mediated activation of forkhead box O1
Peng Xia et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2020)
Apelin/Elabela-APJ: a novel therapeutic target in the cardiovascular system
Wei Liu et al.
ANNALS OF TRANSLATIONAL MEDICINE (2020)
TLR9 deficiency alleviates doxorubicin-induced cardiotoxicity via the regulation of autophagy
Zhen Guo et al.
JOURNAL OF CELLULAR AND MOLECULAR MEDICINE (2020)
[MeArg 1, NLe 10 ]-apelin-12: Optimization of solid -phase synthesis and evaluation of biological properties in vitro and in vivo
Maria Sidorova et al.
PEPTIDES (2020)
MicroRNA-122 aggravates angiotensin II-mediated apoptosis and autophagy imbalance in rat aortic adventitial fibroblasts via the modulation of SIRT6-elabela-ACE2 signaling
Juan-Juan Song et al.
EUROPEAN JOURNAL OF PHARMACOLOGY (2020)
Curcumin suppresses doxorubicin-induced cardiomyocyte pyroptosis via a PI3K/Akt/mTOR-dependent manner
Wei Yu et al.
CARDIOVASCULAR DIAGNOSIS AND THERAPY (2020)
Doxorubicin Exposure Causes Subacute Cardiac Atrophy Dependent on the Striated Muscle-Specific Ubiquitin Ligase MuRF1
Monte S. Willis et al.
CIRCULATION-HEART FAILURE (2019)
Recombinant Fc-Elabela fusion protein has extended plasma half-life andmitigates post-infarct heart dysfunction in rats
Yue Xi et al.
INTERNATIONAL JOURNAL OF CARDIOLOGY (2019)
Cancer treatment and survivorship statistics, 2019
Kimberly D. Miller et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2019)
Nicotinamide riboside promotes autolysosome clearance in preventing doxorubicin-induced cardiotoxicity
Dong Zheng et al.
CLINICAL SCIENCE (2019)
Tanshinone IIA Restores Dynamic Balance of Autophagosome/Autolysosome in Doxorubicin-Induced Cardiotoxicity via Targeting Beclin1/LAMP1
Xiaoping Wang et al.
CANCERS (2019)
Exosome Treatment Enhances Anti-Inflammatory M2 Macrophages and Reduces Inflammation-Induced Pyroptosis in Doxorubicin-Induced Cardiomyopathy
Dinender K. Singla et al.
CELLS (2019)
miR-212/132 Cluster Modulation Prevents Doxorubicin-Mediated Atrophy and Cardiotoxicity
Shashi Kumar Gupta et al.
MOLECULAR THERAPY (2019)
Resveratrol suppresses doxorubicin-induced cardiotoxicity by disrupting E2F1 mediated autophagy inhibition and apoptosis promotion
Jun Gu et al.
BIOCHEMICAL PHARMACOLOGY (2018)
Co-administration of resveratrol with doxorubicin in young mice attenuates detrimental late-occurring cardiovascular changes
Nobutoshi Matsumura et al.
CARDIOVASCULAR RESEARCH (2018)
Left Ventricular Mass Change After Anthracycline Chemotherapy
Jennifer H. Jordan et al.
CIRCULATION-HEART FAILURE (2018)
Quaking Inhibits Doxorubicin-Mediated Cardiotoxicity Through Regulation of Cardiac Circular RNA Expression
Shashi Kumar Gupta et al.
CIRCULATION RESEARCH (2018)
Autophagic dysregulation in doxorubicin cardiomyopathy
Jordan J. Bartlett et al.
JOURNAL OF MOLECULAR AND CELLULAR CARDIOLOGY (2017)
ELABELA and an ELABELA Fragment Protect against AKI
Hong Chen et al.
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2017)
Loss of Apela Peptide in Mice Causes Low Penetrance Embryonic Lethality and Defects in Early Mesodermal Derivatives
Laina Freyer et al.
CELL REPORTS (2017)
TRPC3-Nox2 complex mediates doxorubicin-induced myocardial atrophy
Tsukasa Shimauchi et al.
JCI INSIGHT (2017)
ELABELA-APJ axis protects from pressure overload heart failure and angiotensin II-induced cardiac damage
Teruki Sato et al.
CARDIOVASCULAR RESEARCH (2017)
Elabela/Toddler Is an Endogenous Agonist of the Apelin APJ Receptor in the Adult Cardiovascular System, and Exogenous Administration of the Peptide Compensates for the Downregulation of Its Expression in Pulmonary Arterial Hypertension
Peiran Yang et al.
CIRCULATION (2017)
Characterization of apela, a novel endogenous ligand of apelin receptor, in the adult heart
Abel Perjes et al.
BASIC RESEARCH IN CARDIOLOGY (2016)
Doxorubicin impairs cardiomyocyte viability by suppressing transcription factor EB expression and disrupting autophagy
Jordan J. Bartlett et al.
BIOCHEMICAL JOURNAL (2016)
Doxorubicin Blocks Cardiomyocyte Autophagic Flux by Inhibiting Lysosome Acidification
Dan L. Li et al.
CIRCULATION (2016)
Discovery and Structure-Activity Relationship of a Bioactive Fragment of ELABELA that Modulates Vascular and Cardiac Functions
Alexandre Murza et al.
JOURNAL OF MEDICINAL CHEMISTRY (2016)
VEGF-B gene therapy inhibits doxorubicin-induced cardiotoxicity by endothelial protection
Markus Rasanen et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2016)
Basal autophagy protects cardiomyocytes from doxorubicin-induced toxicity
Marcela Pizarro et al.
TOXICOLOGY (2016)
Sustained ELABELA Gene Therapy in High-salt Diet-induced Hypertensive Rats
Claire A. Schreiber et al.
CURRENT GENE THERAPY (2016)
Doxorubicin Regulates Autophagy Signals via Accumulation of Cytosolic Ca2+ in Human Cardiac Progenitor Cells
Ji Hye Park et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2016)
Possible involvement of downregulation of the apelin-APJ system in doxorubicin-induced cardiotoxicity
Juri Hamada et al.
AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY (2015)
Cardiovascular Disease in Adult Survivors of Childhood Cancer
Steven E. Lipshultz et al.
ANNUAL REVIEW OF MEDICINE, VOL 66 (2015)
Early Detection of Anthracycline Cardiotoxicity and Improvement With Heart Failure Therapy
Daniela Cardinale et al.
CIRCULATION (2015)
Apela Regulates Fluid Homeostasis by Binding to the APJ Receptor to Activate Gi Signaling
Cheng Deng et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2015)
Regulation of autophagy and the ubiquitin-proteasome system by the FoxO transcriptional network during muscle atrophy
Giulia Milan et al.
NATURE COMMUNICATIONS (2015)
Ghrelin inhibits doxorubicin cardiotoxicity by inhibiting excessive autophagy through AMPK and p38-MAPK
Xue Wang et al.
BIOCHEMICAL PHARMACOLOGY (2014)
Prevention of Anthracycline-Induced Cardiotoxicity
Pimprapa Vejpongsa et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2014)
Polyglutamine-expanded androgen receptor interferes with TFEB to elicit autophagy defects in SBMA
Constanza J. Cortes et al.
NATURE NEUROSCIENCE (2014)
Toddler: An Embryonic Signal That Promotes Cell Movement via Apelin Receptors
Andrea Pauli et al.
SCIENCE (2014)
Why should autophagic flux be assessed?
Xiao-jie Zhang et al.
ACTA PHARMACOLOGICA SINICA (2013)
Autophagy upregulation promotes survival and attenuates doxorubicin-induced cardiotoxicity
Balindiwe J. N. Sishi et al.
BIOCHEMICAL PHARMACOLOGY (2013)
ELABELA: A Hormone Essential for Heart Development Signals via the Apelin Receptor
Serene C. Chng et al.
DEVELOPMENTAL CELL (2013)
Left Ventricular Mass in Patients With a Cardiomyopathy After Treatment With Anthracyclines
Tomas G. Neilan et al.
AMERICAN JOURNAL OF CARDIOLOGY (2012)
Decline in the Use of Anthracyclines for Breast Cancer
Sharon H. Giordano et al.
JOURNAL OF CLINICAL ONCOLOGY (2012)
Resveratrol attenuates doxorubicin-induced cardiomyocyte apoptosis in mice through SIRT1-mediated deacetylation of p53
Chi Zhang et al.
CARDIOVASCULAR RESEARCH (2011)
FoxO3 induces reversible cardiac atrophy and autophagy in a transgenic mouse model
Tobias G. Schips et al.
CARDIOVASCULAR RESEARCH (2011)
TFEB Links Autophagy to Lysosomal Biogenesis
Carmine Settembre et al.
SCIENCE (2011)
Nonpegylated liposomal doxorubicin (Myocet™) combination (R-COMP) chemotherapy in elderly patients with diffuse large B-cell lymphoma (DLBCL): results from the phase II EUR018 trial
S. Luminari et al.
ANNALS OF ONCOLOGY (2010)
Autophagy Is Required to Maintain Muscle Mass
Eva Masiero et al.
CELL METABOLISM (2009)
Cell biology - Autophagy as a regulated pathway of cellular degradation
DJ Klionsky et al.
SCIENCE (2000)
Left ventricular dysfunction predicted by early troponin I release after high-dose chemotherapy
D Cardinale et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2000)
分享论文
